Research ArticleCancer

Signaling from mTOR to eIF2α mediates cell migration in response to the chemotherapeutic doxorubicin

See allHide authors and affiliations

Science Signaling  17 Dec 2019:
Vol. 12, Issue 612, eaaw6763
DOI: 10.1126/scisignal.aaw6763

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling